Gene: KCTD21
Official Full Name: potassium channel tetramerization domain containing 21provided by HGNC
Gene Summary: Enables cullin family protein binding activity; histone deacetylase binding activity; and identical protein binding activity. Involved in negative regulation of smoothened signaling pathway and ubiquitin-dependent protein catabolic process. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16796 | KCTD21 Knockout cell line (HeLa) | Human | KCTD21 | 1:3~1:6 | Negative | Online Inquiry |
KO16797 | KCTD21 Knockout cell line (HCT 116) | Human | KCTD21 | 1:2~1:4 | Negative | Online Inquiry |
KO16798 | KCTD21 Knockout cell line (HEK293) | Human | KCTD21 | 1:3~1:6 | Negative | Online Inquiry |
KO16799 | KCTD21 Knockout cell line (A549) | Human | KCTD21 | 1:3~1:4 | Negative | Online Inquiry |
KCTD21 Gene Knockout Cell Lines are genetically modified cell lines engineered to lack the KCTD21 gene, offering researchers a powerful tool for investigating its role in various biological processes and diseases. These knockout cell lines utilize CRISPR-Cas9 technology, a precise and efficient method for gene editing, to disrupt the function of KCTD21 without significantly altering surrounding gene expression. This mechanism enables the study of gene function and its associated pathways in a controlled environment, providing insight into the gene’s involvement in neurodevelopmental disorders and other pathologies.
The scientific importance of KCTD21 Gene Knockout Cell Lines lies in their ability to facilitate research into the gene's function and its implications in various cellular processes, including cell proliferation, differentiation, and signaling pathways. Their applications are particularly valuable in fields such as molecular biology, genetics, and pharmacology, where understanding the consequences of gene loss can aid in drug development and therapeutic interventions.
Compared to traditional knockdown methods like RNA interference, KCTD21 Gene Knockout Cell Lines offer a permanent solution, allowing for the comprehensive assessment of long-term gene effects. Additionally, the use of CRISPR-Cas9 leads to a more robust and reliable knockout, providing more consistent results for experimental reproducibility.
For researchers and clinicians aiming to elucidate the mechanisms underlying disease, KCTD21 Gene Knockout Cell Lines represent a foundational asset in their research toolkit. The capacity to investigate gene function with precision and depth positions these cell lines as an invaluable resource for advancing biomedical knowledge and developing targeted treatments.
Our company specializes in cutting-edge genetic tools and cell line development, ensuring that our products meet the highest standards of quality and efficacy. With a commitment to empowering scientific discovery, we provide innovative solutions that support the advancement of research across diverse fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.